Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,749
Closed -$60.6K 4178
2025
Q4
$60.6K Sell
32,749
-200,038
-86% -$348K ﹤0.01% 4034
2025
Q3
$372K Sell
232,787
-47,002
-17% -$85.9K ﹤0.01% 3726
2025
Q2
$487K Buy
279,789
+250,479
+855% +$419K ﹤0.01% 3542
2025
Q1
$70.3K Sell
29,310
-9,079
-24% -$29.7K ﹤0.01% 3917
2024
Q4
$136K Buy
38,389
+2,460
+7% +$9.73K ﹤0.01% 3916
2024
Q3
$152K Buy
35,929
+998
+3% +$4.32K ﹤0.01% 3785
2024
Q2
$131K Sell
34,931
-826
-2% -$3.76K ﹤0.01% 3746
2024
Q1
$194K Sell
35,757
-7,594
-18% -$43.7K ﹤0.01% 3693
2023
Q4
$267K Sell
43,351
-1,102
-2% -$5.42K ﹤0.01% 3642
2023
Q3
$231K Buy
44,453
+52
+0.1% +$278 ﹤0.01% 3659
2023
Q2
$223K Sell
44,401
-453
-1% -$1.84K ﹤0.01% 3703
2023
Q1
$165K Sell
44,854
-3,783
-8% -$14.3K ﹤0.01% 3767
2022
Q4
$176K Buy
+48,637
New +$255K ﹤0.01% 3731

Other funds holding OABI

Ameriprise's OABI Position: Q1 2026 in Review

Ameriprise sold out of OmniAb (OABI) in Q1 2026, closing a stake of 32,749 shares — an estimated $60.6K sold.

Ameriprise first reported a position in OABI in Q4 2022 and held it in 13 quarters. The position peaked at $487K in Q2 2025. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Ameriprise reported no remaining OmniAb position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 32,749 OmniAb shares in Q1 2026, an estimated $60.6K.
  • Ameriprise first reported a position in OmniAb in Q4 2022 and held it in 13 quarters.
  • Ameriprise's OmniAb position peaked at $487K in Q2 2025.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.